Keywords: icos, starts, trials, oral, lfa-1, antagonist, initiated
ICOS starts trials of oral LFA-1 antagonist
Article | 05 July 2001
ICOS has initiated a Phase I trial to evaluate the safety,tolerability and pharmacokinetics of its orally-active LFA-1 (leukocyte function-associated ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
